TUESDAY, July 8, 2025 (HealthDay News) — Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology. Kenneth Pham, from the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study involving 305,441 […]
The post NRTI Use Linked to Risk for Primary Open-Angle Glaucoma first appeared on Physician’s Weekly.
